Discovery & Intelligence Services – Product Development Service
Whether you’re discovering novel bioactive compounds, validating ingredients, evaluating therapeutic pipelines, analyzing medical device materials, or entering new health markets, Pubrica’s Core Discovery & Intelligence Services transform scientific data into actionable insights.
Discovery and Intelligence Research Services for Product Development: Transforming Ideas into Market-Ready Solutions
Scientific Product Development and Research Gap Analyses
At Pubrica, we offer end-to-end scientific product development services driven by deep discovery and intelligence research to support pharmaceutical, biotechnology, nutraceutical, medical device, cosmeceuticals, herbal, pet health, life sciences, and healthcare organizations.
We built expertise in early-stage discovery, strategic thinking, and regulatory-compliant development, transforming clients’ innovative ideas into safe, effective, and market-ready products from concept to clinic and beyond. We provide primary and secondary research, competitive intelligence, biomarker discovery, medical device discovery services, continuing education, clinical trials, mechanism-of-action studies, pharmacological evaluation, and linked research papers to assure regulatory readiness and formulation suitability, chemical patent evaluation, biocompatibility ISO 10993, therapeutic landscapes, empowering R&D teams with data-driven insights to accelerate innovation and commercialization.
With a proven track record of delivering 1,000+ scientific research projects across pharmaceuticals, nutraceuticals, cosmeceuticals, biotech, herbal, and pet health domains, Pubrica stands as a trusted partner for evidence-driven discovery.
- 500+ subject matter experts in pharmacology, toxicology, clinical studies, and regulatory affairs
- Experience in ingredient/compound intelligence, material compatibility, digital health platforms, biomarker identification, and chemical patent analysis
- In-house capabilities to conduct primary and secondary research with access to worldwide clinical trial databases, peer-reviewed literature, and regulatory sources
- Strong understanding of therapeutic landscapes, bioactive component validation, and formulation readiness
- Support for validating concepts through regulatory-compliant discovery documentation
We bring the depth of scientific rigor and cross-functional expertise needed to guide your discovery process with precision and speed.
What We Do
Our Services – Discovery & Intelligence
At Pubrica, our Discovery & Intelligence Services aim to enhance innovation in all facets of pharmaceuticals, nutraceuticals, biotechnology, herbal, pet health, and medical devices. We provide a comprehensive service to R&D, regulatory, and product development teams to help uncover and confirm data-driven, evidence-based insights to develop drug candidates, raw materials, excipients, novel compounds, and bioactive ingredients.
• Prior Art Search
• Novelty/Patentability Search
• Validity/Invalidity Search
• Infringement Search
• State-of-the-Art Search
These services help our clients safeguard their product ideas, assess IP risks, and make informed decisions in early-stage R&D, especially for novel compounds, ingredients, or formulations.
• Benchmark competing compounds
• Understand trial design strategies
• Support go/no-go decisions
Used for: Drug repositioning, ingredient differentiation, trial planning
• Product positioning
• Gap identification
• Innovation strategy
• Ingredient restrictions
• Claim limitations
• Documentation requirements
Supports: Global product launch readiness
• Regulatory briefs or substantiation reports
• Journal publications to support scientific credibility
• Chemical compatibility with APIs or biological tissues
• Interaction risks (e.g., leachable, degradation products)
• Surface treatment effects on drug/device performance
Supports: Formulation selection, coating systems, and device performance
• Drug adsorption/loss from the container/packaging
• Impact of delivery mechanisms (e.g., pumps, patches, inhalers)
• Stability under storage and usage conditions
• Feature design decisions
• Functional claim development
• Usability study planning
Who We Serve
At Pubrica, we provide Core Discovery & Intelligence Services to a diverse range of industries and organizations developing scientifically grounded, market-ready products. From early-stage research to regulatory-aligned discovery documentation, our services are tailored to meet the distinct R&D needs of each client segment.
Food & Functional Beverage Manufacturers
Support for functional ingredient research, efficacy data collection, and regulatory evidence for novel foods and health claims.
Cosmetics & Personal Care Brands
Ingredient discovery, toxicology intelligence, and mechanism-of-action research to support skin, hair, and oral care formulations aligned with INCI, REACH, and safety assessment standards.
Medical Device Manufacturers
Scientific support for devices that incorporate biologically active materials, combination products, or require regulatory intelligence around material selection and biocompatibility.
Startups & Entrepreneurs
Support in identifying novel ingredients, clinical backing, and competitive intelligence for product concept validation and investor documentation.
Contract Research Organizations (CROs)
Scientific content development, target and compound validation, secondary research, and regulatory literature reviews to support sponsors and submissions.
Academic Institutions & Research Bodies
Collaboration on translational research, technology scouting, and ingredient or compound commercialization through evidence mapping and IP intelligence.
Cosmeceutical & Derma Companies
Scientific evaluation of active ingredients, dermatological evidence collection, and discovery of anti-aging, acne, and skin-repair compounds using clinical and preclinical data.
Pet Food & Veterinary Health Companies
Discovery of safe and effective bioactive herbs and functional ingredients for companion animal health, including clinical support for gut health, joint care, and immune support claims.
Biotechnology Companies
Early-stage discovery services, including gene/protein target validation, biomarker discovery, and mechanism insights to accelerate preclinical programs.
Whether you’re launching a novel compound or validating an existing ingredient, Pubrica’s Discovery & Intelligence Services are built to move you from research to regulatory-ready with clarity and scientific confidence.
The Industry Vertical We Serve
How Our Product Development Service Works
Our step-by-Step Process
At Pubrica, our Core Discovery & Intelligence Services support every stage of product development by delivering scientifically validated insights, starting from idea generation to regulatory-ready evidence. We use a rigorous, research-first approach that combines primary and secondary research, literature mining, patent intelligence, and clinical validation to ensure products are safe, effective, and market-ready.
Ideation & Conceptualization
We begin by understanding your product concept and strategic goals. Through market gap analysis, therapeutic landscape reviews, and competitive intelligence, we help identify high-potential opportunities grounded in unmet needs and innovation potential.
Research & Ingredient Intelligence
Using primary research (expert/KOL interviews, surveys) and secondary research (scientific publications, clinical trials, regulatory sources), we identify and evaluate bioactive ingredients, APIs, and novel compounds, validating their efficacy, safety, and relevance.
Literature & Patent Analysis
We conduct in-depth literature reviews and chemical patent analysis to assess prior art, freedom to operate (FTO), and novelty of proposed ingredients or formulations. This step supports strategic IP planning and regulatory risk reduction.
Scientific Validation & Evidence Building
We compile and synthesize supporting data from clinical studies, biological mechanism research, and toxicology evaluations to strengthen your product’s scientific foundation, enabling regulatory submissions and claims substantiation.
Go-to-Market Intelligence & Strategic Support
We provide insight into launch readiness, competitive positioning, and scientific differentiation, ensuring your product stands out with validated claims and a compelling evidence base.
Speed up your Product development with Pubrica
Pubrica’s Product Development Services provide end-to-end support, from concept ideation to market launch. We ensure scientifically backed formulations, regulatory compliance, and efficient manufacturing for successful product commercialization.
Our Compliance and Guideline Standards
At Pubrica, compliance is embedded into every aspect of our discovery and intelligence services. We follow globally recognized regulatory, ethical, and scientific standards to ensure that all our research outputs, whether for drugs, nutraceuticals, devices, food, or cosmetic products, are court-defensible, regulatory-aligned, and scientifically validated.
We Align With Regulatory Authorities Across Industries
Pharmaceuticals & Biotech- FDA (U.S. Food & Drug Administration)
- EMA (European Medicines Agency)
- ICMR (Indian Council of Medical Research)
- MHRA (UK), TGA (Australia)
- ICH Guidelines (E6 GCP, E9 Statistical Principles)
Nutraceuticals, Herbal & AYUSH- FSSAI (Food Safety & Standards Authority of India)
- AYUSH Ministry (India)
- EFSA (European Food Safety Authority)
- USP Dietary Supplement Compendium
- DSHEA (U.S. Dietary Supplement Health and Education Act)
Cosmetics & Cosmeceuticals- FDA (Cosmetic Regulations – U.S.)
- EU Cosmetic Regulation (EC) No 1223/2009
- REACH (for chemical ingredient safety)
- INCI (International Nomenclature of Cosmetic Ingredients)
Functional Foods & Ingredients - GRAS (Generally Recognized As Safe – U.S.)
- Novel Food Regulation (EU)
- Codex Alimentarius
- FSSAI Nutraceutical & Health Supplement Standards
Pet Food & Veterinary Health- AAFCO (Association of American Feed Control Officials)
- FDA CVM (Center for Veterinary Medicine)
- FEDIAF (European Pet Food Industry Federation)
- APVMA (Australia) for animal products
Medical Devices- FDA 21 CFR Parts 820 (QSR)
- EU MDR 2017/745 (Medical Device Regulation)
- ISO 10993 (Biocompatibility)
- IEC 62304 / ISO 14971 (Software, Risk Management)
- 510(k) & CE Marking Requirements
Scientific & Ethical Guidelines
- Good Clinical Practice (GCP – ICH E6)
- Good Laboratory Practice (GLP – OECD)
- Declaration of Helsinki
- CONSORT, PRISMA, STROBE (for scientific publication standards)
- OECD Guidelines for Toxicity & Safety Studies
- PubMed, Cochrane, and WHO sources for literature evidence
Data Privacy & Confidentiality Compliance- HIPAA (U.S.) – Patient Data Protection
- GDPR (EU) – General Data Protection Regulation
- Indian IT Act & Data Protection Rules
- ClinicalTrials.gov, EUCTR, CTRI transparency standards
Discovery & Intelligence Services Sample Work
Download the full Report Now
Explore our Product Development service sample work, accurately designed to meet industry standards, comply with regulatory requirements, and deliver innovative, high-quality solutions that drive market success.
Product Development Service – Our Packages
Our product development services offer end-to-end solutions, from concept ideation to market-ready products, tailored to meet industry standards and regulatory requirements. Our packages are designed to meet the specific research, validation, and regulatory intelligence needs of pharmaceutical, biotech, nutraceutical, herbal, cosmeceutical, pet health, medical device, and life science companies. Each tier delivers strategic support to accelerate your product’s path from discovery to market.
Starter
For Early Discovery
& Feasibility
- Ideal For: Startups, pre-formulation R&D, early-stage evaluations
- Services Included:
PubMed literature review (efficacy/safety)
Basic clinical trial mapping (relevant to compound/indication)
Ingredient/compound background report
1 therapeutic area overview
Preliminary regulatory guidance (FSSAI, FDA, EMA, etc.)
Advanced
For Validation & Strategy Development
- Ideal For: Teams preparing for formulation, R&D strategy, or investor discussions
- Includes everything in Starter, plus:
Patent landscape & novelty/prior art search
Safety, pharmacological & toxicological profile
Mechanism-of-action evidence mapping
Disease association & therapeutic positioning
Regulatory classification (GRAS, AYUSH, 510(k), etc.)
Comprehensive
For Regulatory & Market-Ready Preparation
- Ideal For: Teams near preclinical, market entry, or submission phase
- Includes everything in Advanced, plus:
Full biomarker & pathway linkage analysis
Competitive product benchmarking
Regulatory landscape & dossier readiness report
Claims substantiation matrix
Drafting of white papers or regulatory briefs
Optional: Biocompatibility literature review (for medical devices)
Custom
Tailored Research &
Intelligence Solutions
- Ideal For: Clients with unique compound types, niche indications, or global compliance needs
- Options may include:
Veterinary or pet food ingredient analysis
Cosmeceutical ingredient toxicity & INCI alignment
Combination product (drug-device) compatibility studies
Delivery system innovation mapping
Sustainability & sourcing intelligence
Post-market literature surveillance
All Packages Include:
- Support from Pubrica’s 500+ domain experts
- Reports aligned with global regulatory authorities (FDA, EMA, EFSA, FSSAI, AYUSH, etc.)
- Scientifically defensible evidence based on Level A research, clinical trials, and validated databases
Testimonials
Our product development services offer expert support to businesses, entrepreneurs, and researchers by providing innovative solutions backed by industry standards. Here’s what some of our clients say:
"Pubrica’s scientific research team delivered a comprehensive literature and biomarker review that strengthened our regulatory submission in the EU. Their clinical evidence and mechanism-of-action research was impressive. "
— Elena Morris
Regulatory Affairs Manager, PharmaGenix, Germany
"We were impressed by Pubrica’s ability to translate complex clinical data into a clear, defensible claim strategy. Their work in patent analysis and ingredient mapping was key to our U.S. nutraceutical launch."
— Thomas Reynolds
Director of R&D, NutraCore Labs, USA
"As an herbal supplement company, we needed deep validation for our formulation. Pubrica’s team provided detailed secondary research, supported by regulatory-aligned insights from WHO and AYUSH sources."
— Rajesh Kumar
CEO, Nutraceutical Innovations, India
"Pubrica’s discovery insights into pet health ingredients, combined with their knowledge of AAFCO and FDA-CVM guidelines, helped us confidently position our new veterinary formula for the North American market."
— Sophie Grant
Product Strategy Lead, VetLife Science, Canada
"The scientific intelligence Pubrica delivered from therapeutic landscape mapping to regulatory pathway planning helped us fast-track early decisions for our oncology pipeline."
— Sanya Patel
Head of Translational Science, OncoTech Biologics, UK
"Pubrica's team provided exceptional support in finalizing my cross-sectional study on adolescent nutrition. Their attention to ethical standards and STROBE compliance helped secure acceptance in BMC Public Health without major revisions."
Dr. Anitha Raj,
Assistant Professor, India
"The scientific accuracy and journal-specific formatting were excellent. Pubrica structured the manuscript precisely to match the Journal of Translational Medicine submission format, especially in compliance with STROBE guidelines. This significantly accelerated the peer-review outcome.”
Prof. Markus Klein,
Biomedical Researcher, Germany
"Pubrica’s team demonstrated high-level scientific expertise in writing and structuring my oncology manuscript. Their adherence to CONSORT guidelines and formatting as per the Asian Pacific Journal of Cancer Prevention ensured quick peer acceptance. Highly recommended for clinicians aiming for an indexed publication.”
Dr. Sanjay Menon,
Clinical Oncologist, India
Frequently Asked Questions – Core Discovery & Intelligence Services
We provide in-depth regulatory intelligence by reviewing region-specific guidelines from FSSAI, FDA, EMA, AYUSH, EFSA, and others. Our experts align discovery insights with the relevant regulatory frameworks, helping you understand ingredient restrictions, allowable claims, documentation requirements, and classification pathways (e.g., GRAS, novel food, 510(k)). This ensures that your product concept is regulatory-ready from the start.
The timeline depends on the complexity of the research. A basic literature review or PubMed-based analysis may take 2–3 weeks. More comprehensive discovery projects involving biomarker mapping, patent searches, regulatory landscape reviews, or ingredient validation can take 6–10 weeks. Custom projects are scoped based on required depth and markets targeted.
Yes. Our team conducts primary and secondary research to identify clinically supported ingredients, bioactive compounds, or raw materials suitable for your indication or formulation goal. We evaluate evidence from clinical trials, toxicological data, and mechanism-of-action studies, supporting ingredient selection with scientific and regulatory justification.
We perform literature reviews, clinical trial mapping, claims substantiation, and regulatory classification analysis for ingredients used in nutraceuticals, functional foods, and dietary supplements. This helps you validate efficacy, understand disease associations, and ensure compliance with health claims guidelines from FSSAI, EFSA, FDA/DSHEA, and others.
Yes. We provide material compatibility reviews, ISO 10993 biocompatibility literature analysis, and regulatory pathway insights for medical devices and combination products. We also assist in identifying predicate devices, conducting risk-based reviews, and assessing drug-device interactions for submission readiness.
Yes. We prepare scientific literature reviews, pharmacological and toxicological summaries, biomarker/pathway mappings, and regulatory briefs aligned with global authorities. These deliverables are suitable for dossier support, claims substantiation, and scientific communication in the context of market authorization or investment readiness.
Insights
How to Structure Case Reports and Review Articles for Medical Journals
Medical journals expect a structure for case reports and review articles, with clear objectives....
How Should Physicians Choose the Right Journal for Submitting a Case...
Publishing a case report involves more than clinical knowledge; it also demands strategic journal ....
How Physicians Can Write Clear and Impactful Patient Education Materials
Effective patient education materials (PEMs) are crucial for promoting health literacy, enhancing....